Stem Cells http://www.peprotech.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


First published online July 5, 2007
This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
2007-0017v1
25/10/2610    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bozorgmehr, F.
Right arrow Articles by Fruehauf, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bozorgmehr, F.
Right arrow Articles by Fruehauf, S.
Submitted on January 25, 2007
Accepted on June 18, 2007

THE STEM CELL NICHE

No Evidence of Clonal Dominance in Primates up to Four Years Following Transplantation of Multidrug Resistance 1 Retrovirally-Transduced Long-term Repopulating Cells

F. Bozorgmehr 1, S. Laufs 2, S. E. Sellers 3, I. Roeder 4, W. J. Zeller 1, C. E. Dunbar 3, S. Fruehauf 5*

1 Research Group Pharmacology of Cancer Treatment, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
2 Clinical Cooperation Unit Molecular Oncology of Solid Tumors, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, 69120 Heidelberg, Germany
3 Hematology Branch, National Heart, Lung and Blood Institute, Bethesda, MD 20892, USA
4 Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Haertelstrasse 16/18, 04107 Leipzig, Germany
5 Department of Internal Medicine V, University of Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany; Center for Tumor Diagnostics and Therapy, Paracelsus Klinik, Am Natruper Holz 69, 49076 Osnabrueck, Germany

* To whom correspondence should be addressed. E-mail: prof.stefan.fruehauf{at}pk-mx.de.


   Abstract

Previous murine studies have suggested that retroviral multidrug resistance 1 (MDR1) gene transfer may be associated with a myeloproliferative disorder. Analyses at a clonal level, and prolonged long-term follow-up in a model with more direct relevance to human biology were lacking. In this study we analyzed the contribution of individual CD34-selected peripheral blood progenitor cells (PBPCs) to long-term rhesus macaque hematopoiesis after transduction with a retroviral vector either expressing the multidrug resistance 1 gene (HaMDR1 vector) or expressing the neomycin resistance (NeoR) gene (G1Na vector). We found a total of 122 contributing clones from 8 weeks up to 4 years after transplantation. 102 clones contained the G1Na vector, whereas only 20 clones contained the HaMDR1 vector. Here, we show for the first time real-time PCR based quantification of individual transduced cell clones constituting 0.0008%±0.0003% to 0.0041%±0.00032% of primate peripheral blood cells. No clonal dominance was observed.

Key Words. gene therapy, multidrug resistance 1, CD34+, rhesus macaque




This article has been cited by other articles:


Home page
Stem CellsHome page
F. Ahmed, N. Arseni, H. Glimm, W. Hiddemann, C. Buske, and M. Feuring-Buske
Constitutive Expression of the ATP-Binding Cassette Transporter ABCG2 Enhances the Growth Potential of Early Human Hematopoietic Progenitors
Stem Cells, March 1, 2008; 26(3): 810 - 818.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.stemcellsportal.com/
Copyright © 2007 by AlphaMed Press.